Company Filing History:
6 out of 815 
4 out of 9 
4 out of 134 
Years Active: 2017-2022
Title: Innovations by Subhash G Vasudevan
Introduction
Subhash G Vasudevan is a prominent inventor based in Singapore, known for his significant contributions to the field of medical science. With a portfolio of six patents, he has focused on developing therapeutic solutions to combat viral infections, particularly those caused by the Zika and dengue viruses. His innovative work is instrumental in advancing therapeutic and diagnostic methods vital for public health.
Latest Patents
One of his latest patents includes a groundbreaking development of antibodies that bind to the Zika virus envelope protein. This innovation details isolated monoclonal antibodies along with related antibody-based compositions and molecules, enabling various therapeutic and diagnostic applications. Another notable patent addresses methods for treating dengue virus infections in humans by administering a specific compound in defined dosing regimens. This regimen outlines administration during the onset of fever to enhance patient outcomes for individuals suffering from primary and secondary dengue viral infections.
Career Highlights
Throughout his career, Subhash G Vasudevan has worked with prestigious organizations. He has significantly contributed to the National University of Singapore and 60 Degrees Pharmaceuticals, LLC, where his research has focused on virology and immunology. His dedication to medical research exemplifies his commitment to improving global health.
Collaborations
During his journey as an inventor, Subhash has collaborated with renowned professionals in the field. Notable coworkers include Satoru Watanabe and Eng Eong Ooi, with whom he has worked closely on various research projects and innovations aimed at bettering health solutions for viral infections.
Conclusion
Subhash G Vasudevan stands out as a leading innovator in the healthcare industry, particularly in the realm of viral infection treatment. His patents reflect a deep understanding of the health challenges posed by viruses such as Zika and dengue. Through his continued research and collaborations, Subhash is paving the way for more effective therapeutic and diagnostic approaches that have the potential to significantly impact public health outcomes.